97 related articles for article (PubMed ID: 15035153)
1. [Type I collagen crosslinked C-telopeptides].
Hoshino H; Kushida K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():365-8. PubMed ID: 15035153
[No Abstract] [Full Text] [Related]
2. [Cross-linked N-telopeptides of type I collagen(NTX)].
Saito S; Nakatsuka K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():358-62. PubMed ID: 15035152
[No Abstract] [Full Text] [Related]
3. [The significance of bone biochemical markers and its application for clinics].
Nishijima R; Kamimiya F; Horiuchi T
Nihon Rinsho; 2004 Feb; 62 Suppl 2():333-8. PubMed ID: 15035147
[No Abstract] [Full Text] [Related]
4. [N-terminal crosslinking telopeptide of type I collagen].
Fukunaga M
Nihon Rinsho; 2004 Dec; 62 Suppl 12():236-9. PubMed ID: 15658308
[No Abstract] [Full Text] [Related]
5. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
6. [Beta-crosslaps].
Mori M
Nihon Rinsho; 2004 Dec; 62 Suppl 12():247-9. PubMed ID: 15658311
[No Abstract] [Full Text] [Related]
7. Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004).
Nishizawa Y; Nakamura T; Ohta H; Kushida K; Gorai I; Shiraki M; Fukunaga M; Hosoi T; Miki T; Chaki O; Ichimura S; Nakatsuka K; Miura M;
J Bone Miner Metab; 2005; 23(2):97-104. PubMed ID: 15750686
[No Abstract] [Full Text] [Related]
8. [Biochemical markers for bone turnover: Serum beta-CTX].
Ichimura S; Iwamoto J
Nihon Rinsho; 2007 Nov; 65 Suppl 9():237-44. PubMed ID: 18161112
[No Abstract] [Full Text] [Related]
9. [Bone resorption markers].
Takahashi M; Inoue T
Rinsho Byori; 1996 May; 44(5):415-22. PubMed ID: 8676559
[TBL] [Abstract][Full Text] [Related]
10. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
11. [Serum beta-CTx(beta-CrossLaps)].
Okabe R
Nihon Rinsho; 2004 Feb; 62 Suppl 2():369-72. PubMed ID: 15035154
[No Abstract] [Full Text] [Related]
12. [Outline of Guidelines 2004 for bone marker in osteoporosis].
Nishizawa Y
Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
[No Abstract] [Full Text] [Related]
13. Urinary type I collagen cross-linked N-telopeptides in inhabitants 18 years after cessation of exposure to cadmium in Japan.
Omote S; Kido T; Nishijo M; Nakagawa H; Suwazono Y; Kobayashi E; Nogawa N
Bull Environ Contam Toxicol; 2006 Feb; 76(2):187-94. PubMed ID: 16467995
[No Abstract] [Full Text] [Related]
14. How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?
Mundy GR
Nat Clin Pract Oncol; 2005 May; 2(5):242-3. PubMed ID: 16264958
[No Abstract] [Full Text] [Related]
15. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
[TBL] [Abstract][Full Text] [Related]
16. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.
Eastell R; Barton I; Hannon RA; Chines A; Garnero P; Delmas PD
J Bone Miner Res; 2003 Jun; 18(6):1051-6. PubMed ID: 12817758
[TBL] [Abstract][Full Text] [Related]
17. Urinary markers of type I collagen degradation in the dog.
Allen MJ; Allen LC; Hoffmann WE; Richardson DC; Breur GJ
Res Vet Sci; 2000 Oct; 69(2):123-7. PubMed ID: 11020362
[TBL] [Abstract][Full Text] [Related]
18. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
19. [Long-term bisphosphonate administration and its effect on bone metabolism].
Hagino H
Clin Calcium; 2005 Apr; 15(4):643-7. PubMed ID: 15802778
[TBL] [Abstract][Full Text] [Related]
20. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
